Background-Existing models for outcome after percutaneous coronary interventions (PCIs) lack assessment of long-term prognosis. Our goal was to derive 1-and 5-year mortality and mortality/myocardial infarction (MI) risk models for PCI outcomes from simple, easily obtainable clinical and laboratory variables. Methods and Results-Using the Mayo Clinic registry, we analyzed long-term mortality and mortality/MI following PCIs on 9165 unique patients from January 1, 2001, through December 31, 2007. Cox proportional hazards regression was used to model the calculated risk score and major procedural complications. A total of 1243 patients died, and 696 had MI. Separate risk models derived from clinical, procedural, and laboratory characteristics were made for mortality and mortality/MI. Older age, comorbid conditions, low ejection fraction, acute MI, history of smoking, heart failure, hyperlipidemia, 3-vessel disease, procedural failure, ventricular arrhythmia during PCI, and low medication score were predictors of long-term mortality and mortality/MI. Simple integer scores stratified patients into low, moderate, high, and very high risk for subsequent events. Models had adequate goodness of fit, and areas under the receiver operating characteristic curve were 0.786 and 0.728 for mortality and mortality/MI, respectively, indicating good overall discrimination. Bootstrap analysis indicated that the model was not overfit to the available data set. Conclusions-Easily obtainable variables can be combined into a convenient risk scoring system at the time of patient dismissal following PCI to accurately predict long-term mortality and mortality/MI. This model may be useful for providing patients with individualized, evidence-based estimates of long-term risk. (Circ Cardiovasc Interv. 2010; 3:423-430.)
L ong-term prognostic data in patients with coronary heart disease are useful for informed consent and clinical decision-making and may be helpful in making policy decisions and comparing outcome data among hospitals. Risk adjustment models can account for case mix and allow fair comparisons of short-and long-term outcomes in observational studies.
Clinical Perspective on p 430
More than 1 million patients undergo percutaneous coronary interventions (PCIs) in the United States annually. Risk prediction models that evaluate outcomes have been limited to in-hospital complications. [1] [2] [3] [4] [5] [6] Several such models that provide parsimonious information on in-hospital events, 3, 4, 6 however, do not predict long-term prognosis. Long-term outcome studies derive from trial-based populations undergoing PCI, thereby limiting generalizability, or derive from selected subgroups, such as patients with myocardial infarction (MI). 7, 8 Most such studies are old and provide historical comparisons that are less relevant to a contemporary population undergoing PCI. Additionally, the covariates for inhospital outcomes may not predict late events, underscoring the need to develop long-term models. 9 To address these issues, we developed and validated 2 late-risk prediction models following PCI. We integrated demographic, clinical, and procedural variables as well as used evidence-based medications on dismissal as variables toward model development. These risk models are built to complement the inhospital risk scores rather than to replace them. To maximize the usability of the models, we also present simplified versions.
Methods

Mayo Clinic PCI Registry
The Mayo Clinic PCI Registry includes clinical, procedural, and angiographic data on all patients undergoing PCI. A research nurse contacts all patients at 6 months, 12 months, and annually after PCI. Medical records, including ECGs, death certificates, and laboratory parameters of all patients requiring hospitalization at Mayo Clinic (Rochester, Minn), or elsewhere, are reviewed to further characterize any clinical events during follow-up. Random monthly audits of data by the study coordinators are performed to identify and rectify inconsistencies in the data.
Current Study
This analysis was conducted on PCIs that were performed from January 1, 2001, through December 31, 2007. There were 9654 patients treated during this time period; 9165 granted use of their records for research and were included in this study. Of this final sample, 1243 patients died, and 696 experienced nonfatal MI. Approval for the study was obtained from the Mayo Clinic Institutional Review Board. Patients who denied research authorization (nϭ489) were excluded from the study in accordance with Minnesota state law.
Definitions
Mortality was defined as any death (all-cause mortality) during follow-up. Patients with sudden cardiac death were included in the analyses. Death certificates were obtained whenever possible and reviewed. The second main outcome was MI, defined as presence of 2 of the 3 following criteria: prolonged (Ն20 minutes) ischemic chest pain, and elevation of cardiac biomarkers (creatine kinase-MB or relative index) Ͼ2 times the upper limit of normal, and ECG changes (ST-or T-wave changes or new Q waves).
We considered 4 classes of variables (demographic, comorbid conditions, procedural, and evidence-based medications at dismissal) as potential predictors of mortality and MI based on available long-term outcome studies in patients undergoing PCI. 10 -12 The demographic variables included age, body mass index (BMI), MI (1 to 7 or Ͼ7 days before PCI), ejection fraction, history of hyperlipidemia (cholesterol Ն240 mg/dL), smoking, coronary artery bypass graft (CABG), and congestive heart failure (CHF).
Comorbid conditions were measured by a previously published coronary artery disease (CAD) index. 13 Information on comorbid conditions was collected at the time of the index PCI and was abstracted from the patients' medical records. In brief, the CADspecific index was developed to assess and determine the prognostic influence of comorbid conditions from a cohort of 1471 patients with CAD who underwent coronary angiography between 1985 and 1989 and were followed until 2000 by the Duke Databank for Cardiovascular Diseases. After the final model was determined, a weight for each comorbid condition was derived using the log hazard ratios from the model. A weight of 2 was assigned to diabetes mellitus, and weights for the other conditions were calculated relative to diabetes and rounded to the nearest integer (Table 1) . In this study we separated the patients into 3 groups: those with a CAD-specific index score of 0 or 1; those with a score of 2 or 3, and those with a score of Ն4 (maximum score observed in our sample was 20).
In the procedural category, we examined preprocedure troponin levels, procedural failure, and incidence of ventricular arrhythmia (sustained ventricular tachycardia or ventricular fibrillation) during PCI, 3-vessel disease, and use of glycoprotein (GP) IIb/IIIa inhibitors during the procedure. For predismissal medications, a medication score (MEDS) was assigned to each patient based on the medications at discharge from the hospital. 14 A MEDS of 1 was added for each of the following medication classes: antiplatelets (aspirin), ␤-blockers, angiotensin-converting enzyme inhibitors, and lipidlowering agents. Therefore, a MEDS of 0 means that the patients were discharged on none of these medication classes, and a MEDS of 4 means that they were discharged on all 4 of them. The patients were then grouped into 4 categories: MEDS 0 or 1, MEDS 2, MEDS 3, MEDS 4.
Statistical Methods
Continuous variables are summarized as meanϮSD, unless otherwise noted. Categorical variables are presented as frequency (percentage). Time to event was defined as the days from discharge of the first qualifying PCI to the first occurrence of the event of interest. If patients had multiple qualifying PCIs before an event, then the patient and procedural characteristics of the subsequent PCIs were included in the model using time-dependent covariates. The values of the explanatory variables were changed at the time since the first PCI. In this way, events were not double counted, and information from multiple PCIs was not discarded.
To avoid overfitting, risk factors for each end point were prespecified. These variables were age at discharge, sex, MI within 24 hours before PCI, MI within 1 to 7 days before PCI, history of MI Ͼ7 days before PCI, pre-PCI shock, unstable angina, stable angina, preprocedure troponin Ն0.01, CAD comorbidity index, history of CHF, BMI, history of cholesterol Ͼ240 mg/dL, former-smoker, prior PCI, prior CABG, ejection fraction, 3-vessel disease, stent use, GP IIb/IIIa inhibitor use (before or during PCI), procedural failure, in-hospital ventricular arrhythmia (tachycardia or fibrillation) complication, and discharge MEDS. The following interactions also were prespecified: age and CAD comorbidity index, age and CHF, 3-vessel disease and MEDS, and age and discharge MEDS.
Missing variables were handled using multiple imputation. Five multiple imputation data sets were created. 15 Of the variables selected for modeling, ejection fraction was the variable most frequently missing (45%) followed by number of diseased vessels (8%), history of cholesterol Ͼ240 mg/dL (8%), baseline troponin (8%), and CHF history (6%). Fourteen percent of the time at least 1 component of the CAD index was missing. The CAD index components were imputed individually and the composite calculated after imputation. All other modeling variables had Ͻ5% missing values.
For each end point, the model was developed as follows. The prespecified main effects were fit to the end point using a Cox multiple regression model for each multiple imputation data set. Splines were used to model the associations between continuous variables and the end point. Prespecified interactions also were included. An estimate of the shrinkage for each model was calculated without printing individual parameter estimates or tests of significance. Additionally, a single likelihood ratio test was calculated for all interactions. If this test was significant, then all interactions were retained; otherwise, all interactions were removed. If 4 of the 5 shrinkage estimates were Ͼ0.90, then no variables were removed from the model. Otherwise, data reduction methods independent of associations with the end point were used to select variables to be removed. Examples of such methods include investigating correlations between variables and removing 1 of 2 that were highly correlated, removing a variable believed to be clinically less relevant than others, removing risk factors of low prevalence, and using fewer degrees of freedom for nonlinear associations.
Once variables were finalized, the assumption of proportional hazards was inspected by plotting Schoenfeld residuals and a smoother against a function of time. Variables that appeared to violate the assumption were tested formally by adding a timedependent interaction between the variable and the log of time. Some variables were chosen a priori as likely candidates to violate the proportional hazard assumption. If the test of these variables was significant at the 0.05 level, then the model was extended to reflect the violation. Tests for variables not prespecified as likely to violate the assumption had to meet a 0.0025 significance level (based on the assumption that there may be 20 such tests) to require extending the model. Integer scores were developed by dividing the model parameter estimates by a divisor (D) chosen such that all statistically significant variables have a nonzero contribution toward the integer score. We started with a D Ͻ1 and a multiple of 0.01 and iterated downward by steps of 0.01 until we found a D that met the criteria. Thus, at each iteration for each patient, we calculated an array of integer summands by dividing the parameter estimates by D and rounding to the nearest integer. For variables modeled nonlinearly as splines, we added all spline effects together first and then divided by D. The iterative process was stopped at the value of D, which met the criteria that all significant variables have some contribution toward the integer score.
The expected 1-and 5-year event rates for the integer scores were calculated from a Cox proportional hazards model regressing the end point on the integer score. Kaplan-Meier estimates were used to obtain the observed event rates by integer score. The discriminatory ability of the score was assessed by the modified C statistic. 16 
Handling Missing Data
In practice, some risk factors may be unmeasured. We inspected the difference in the integer scores between the fully imputed data and 
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the incomplete data and determined the following recommendations for handling missing data. If ejection fraction was unknown, we added 1 point to the score for death and 1 to death/MI if the patient had a history of CHF. If troponin values were unknown, 1 point was added to both scores if the patient had an MI within 7 days of PCI. If multiple components of the CAD index were missing, 1 point was added to the CAD index if 2 to 4 components were missing, and 2 points were added if Ն5 were missing. All other risk factors were treated as absent or normal if they were unmeasured.
Results
Baseline Characteristics
There were 10 795 PCIs on 9165 unique patients. The mean age of the patients was 66.8Ϯ12.2 years, 29% were women, 54% presented with unstable angina, and 20% presented with acute MI. Other patient characteristics are summarized in Table 2 . Univariate associations between baseline demographic characteristics and procedural mortality and mortality/MI are shown in Table 3 . Tables 4 and 5 present the results of the multiple imputation analysis of Cox proportional hazards regression models for mortality and mortality/MI, respectively. In both models, there was no significant evidence of violation of the proportional hazards assumption. For death, the overall test of significance of the prespecified interaction terms was significant (PϽ0.001); hence, all were retained. For death/MI, this test was not significant (Pϭ0.16), and these terms were dropped from the model.
Integer Risk Score
The simplified, integer-based risk scores are shown in Tables  6 and 7 . The final risk score for an individual patient can be calculated by adding the points for each risk factor present. The 1-and 5-years plots for mortality and mortality/MI are shown in Figures 1 and 2 , demonstrating worse outcomes with higher integer scores.
It may be convenient to further simplify patients' estimated 1-year risk into categories such as low risk (Ͻ2.5%), moderate risk (2.5% to 5%), high risk (5% to 10%), and very high risk (Ͼ10%). The ranges of the mortality score for such a classification would be Յ4, 5 to 6, 7 to 8, and Ն9, which were observed in 49%, 24%, 17%, and 10% of patients, respectively. The ranges of the mortality/MI score would be Յ1, 2 to 4, 5 to 8, and Ն9, which were observed in 15%, 32%, 35%, and 18% of patients, respectively. Furthermore, these categories correspond to 5-year risk estimates of Ͻ10%, 10% to 20%, 20% to 40%, and Ͼ40%.
Validation
For internal validation, we created 100 bootstrap samples and calculated the C statistics and the observed and expected mortality and mortality/MI rates. For mortality, the mean C statistic was 0.786Ϯ0.0065. The average differences between the observed and expected 1-year mortality rates for low-, moderate-, high-, and very highrisk groups were Ϫ0.2% and 0.1%, Ϫ0.2% and 0.3%, 1.4% and 0.7%, and 0.6% and 1.3%, respectively, and for 5-years, they were Ϫ0.05% and 0.5%, 0.4% and 1.1%, 3.5% and 1.4%, and Ϫ4.3% and 1.9%, respectively. For the mortality/MI model, the mean C statistic was 0.737Ϯ0.0062. The average differences between observed and expected 1-year mortality/MI rates for low-, moderate-, high-, and very high-risk groups were 0.1% and 0.4%), Ϫ0.7% and 0.2%, 0.2% and 0.4%, and 1.1% and 1.3%, respectively, and for observed and expected 5-year mortality/MI rates, they were Ϫ0.3% and 1.2%, Ϫ1.3% and 0.7%, 1.3% and 0.9%, and 0.6% and 1.8%.
Discussion
We developed and validated 2 risk models that accurately predicted long-term prognosis of patients undergoing PCI for both mortality and the composite of mortality/MI. These models are simple and easy to use, and the requisite inputs are easily obtainable. Both models have good calibration as seen by the similar mortality and mortality/MI rates in the development and validation cohorts and good discrimination with C statistic indices of 0.788 and 0.727. These models stratify patients into 4 distinctive risk groups with 1-and 5-year estimated risk ranging from Ͻ2.5% and Ͻ10% in patients at low risk to Ͼ10% and Ͼ40% in patients at very high risk. Such categorization can facilitate communication of quanti- tative information to patients and may help with clinical decision-making. There are several unique features of these models that demonstrate the importance of comorbid conditions and dismissal on evidence-based MEDS. Patients with fewer comorbid conditions and high MEDS have better long-term overall survival and survival free of MI. PCI is increasingly being performed in elderly patients; thus, a major impact of comorbidity on outcome is expected. 9, 17 Comorbidity, however, is not included in any of the scores derived from clinical trials, which typically include younger persons. We previously demonstrated improvement in the risk stratification of community cohorts presenting with MI and patients undergoing PCI with the addition of comorbid conditions, underscoring the need for their inclusion in estimation of long-term prognosis. 9, 17 Similarly, other variables, prevalent in elderly patients undergoing PCI, including frailty, poor health status, and functionality, are likely to influence long-term prognosis and may need to be included in risk adjustment models. 18 -20 Lee and colleagues 11 recently reported a 4-year mortality prognostic index in a community-based cohort of adults aged Ͼ50 years and found that self-reported comorbid conditions and functional measures accurately stratified adults into varying risks of mortality.
Discharge of patients on all the evidence-based medications is crucial to reduce long-term mortality and mortality/ MI. 14 An adjusted MEDS score of 3 to 4 was associated with significantly lower mortality or mortality/MI at follow-up than a MEDS of 0 to 1 (MEDS 3 hazard ratio, 0.72; MEDS 4 hazard ratio, 0.67; PϽ0.01). Identification of factors associated with postdismissal mortality after successful PCI may trigger more frequent surveillance and more intensive medical management.
No risk adjustment tools are currently available by which patients or healthcare providers can estimate long-term overall survival and survival free of MI after PCI. The parsimonious nature of the models and ease of their application in daily practice is a step toward delivery of evidence-based, individualized medicine. The ubiquity of risk factors that determine outcome regardless of mode of revascularization may extend the usage of these models in patients undergoing CABG as well. 6, 21, 22 
Limitations
The single-center nature of this study in a fairly homogenous population is a limitation, and our models require validation in other centers and populations before widespread clinical adoption can be recommended. Ejection fraction data were missing in a subset of patients in our sample. We used multiple imputation techniques to allow inclusion of all patients for unbiased estimates. We did not have information on other potentially important variables, such as frailty, disability, and other functional measures known to affect prognosis. 20 Moreover, we only have data on the treatment given at time of dismissal; compliance with medications is not known. Furthermore, future medical advances may improve survival relative to the patients studied here. Extrapolation of these findings to other patients with CAD needs further study.
Conclusions
The Mayo Clinic risk scores for long-term mortality and mortality/MI accurately predict prognosis following PCI and may be useful tools for patients and healthcare providers. These models will provide complementary prognostic information to the existing prediction models for in-hospital outcomes following PCI.
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